Mucosal patterns change after Helicobacter pylori eradication: Evaluation using blue laser imaging in patients with

Yoshiyuki Nishikawa1, Yoshio Ikeda2, Hidehiro Murakami3

  • 1Department of Gastroenterology, Nishikawa Gastrointestinal Clinic, Matsuyama 790-0878, Ehime, Japan. yonishik@ehime.med.or.jp.

Abstract

Insights

After Helicobacter pylori eradication, mucosal patterns in atrophic gastritis predominantly shift from spotty to cracked. This transformation aids endoscopists in accurately assessing H. pylori-related gastritis.

Area of Science:

  • Gastroenterology
  • Endoscopy
  • Microbiology

Background:

  • Atrophic gastritis is characterized by distinct mucosal patterns (MPs) observable via blue laser imaging: spotty, cracked, and mottled.
  • A hypothesis suggests that the spotty MP may evolve into a cracked MP following successful Helicobacter pylori eradication.

Purpose of the Study:

  • To comprehensively investigate and confirm MP alterations after H. pylori eradication in a larger patient cohort.
  • To provide further evidence for the dynamic changes in mucosal patterns post-H. pylori treatment.

Main Methods:

  • A cohort of 768 patients with atrophic gastritis and evaluable MPs underwent upper gastrointestinal endoscopy.
  • 101 H. pylori-positive patients with evaluable MPs before and after eradication therapy were analyzed for MP changes.
  • MPs were independently assessed by three blinded, experienced endoscopists.

Main Results:

  • Following H. pylori eradication, 88.2% of patients with the spotty pattern showed its disappearance or reduction.
  • The cracked pattern increased or appeared in 87.8% of patients, while the mottled pattern showed a 50.0% increase or appearance.
  • Significant shifts in MPs were observed, with the spotty pattern frequently resolving and the cracked pattern emerging post-eradication.

Conclusions:

  • H. pylori eradication leads to a predominant transformation of mucosal patterns from spotty to cracked in patients with atrophic gastritis.
  • These observed MP changes offer a valuable tool for endoscopists to more easily and precisely evaluate H. pylori-related gastritis status.

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
162
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
470
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
345
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
120
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
393